Class information for:
Level 1: DPP 4 INHIBITOR//SITAGLIPTIN//VILDAGLIPTIN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
4292 1735 40.4 85%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
461 15321 NEUROPEPTIDE Y//GLUCAGON LIKE PEPTIDE 1//GLP 1

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DPP 4 INHIBITOR Author keyword 184 72% 8% 146
2 SITAGLIPTIN Author keyword 179 57% 12% 210
3 VILDAGLIPTIN Author keyword 172 68% 9% 151
4 ALOGLIPTIN Author keyword 156 90% 4% 69
5 LINAGLIPTIN Author keyword 155 81% 5% 95
6 SAXAGLIPTIN Author keyword 135 78% 5% 90
7 DIPEPTIDYL PEPTIDASE 4 INHIBITOR Author keyword 125 74% 5% 93
8 DIPEPTIDYL PEPTIDASE 4 Author keyword 92 57% 6% 110
9 MK 0431 Author keyword 86 96% 1% 26
10 DPP 4 Author keyword 83 65% 5% 80

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 DPP 4 INHIBITOR 184 72% 8% 146 Search DPP+4+INHIBITOR Search DPP+4+INHIBITOR
2 SITAGLIPTIN 179 57% 12% 210 Search SITAGLIPTIN Search SITAGLIPTIN
3 VILDAGLIPTIN 172 68% 9% 151 Search VILDAGLIPTIN Search VILDAGLIPTIN
4 ALOGLIPTIN 156 90% 4% 69 Search ALOGLIPTIN Search ALOGLIPTIN
5 LINAGLIPTIN 155 81% 5% 95 Search LINAGLIPTIN Search LINAGLIPTIN
6 SAXAGLIPTIN 135 78% 5% 90 Search SAXAGLIPTIN Search SAXAGLIPTIN
7 DIPEPTIDYL PEPTIDASE 4 INHIBITOR 125 74% 5% 93 Search DIPEPTIDYL+PEPTIDASE+4+INHIBITOR Search DIPEPTIDYL+PEPTIDASE+4+INHIBITOR
8 DIPEPTIDYL PEPTIDASE 4 92 57% 6% 110 Search DIPEPTIDYL+PEPTIDASE+4 Search DIPEPTIDYL+PEPTIDASE+4
9 MK 0431 86 96% 1% 26 Search MK+0431 Search MK+0431
10 DPP 4 83 65% 5% 80 Search DPP+4 Search DPP+4

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DIPEPTIDYL PEPTIDASE 4 INHIBITOR 304 58% 20% 348
2 DPP 4 INHIBITOR 182 89% 5% 82
3 VILDAGLIPTIN 179 75% 7% 130
4 IV INHIBITOR 168 68% 8% 147
5 SITAGLIPTIN 130 49% 11% 191
6 BI 1356 103 93% 2% 39
7 INITIAL COMBINATION THERAPY 82 65% 5% 79
8 GLUCAGON LIKE PEPTIDE 1 74 11% 35% 612
9 ONGOING METFORMIN THERAPY 73 73% 3% 56
10 DPP 4 INHIBITORS 67 77% 3% 46

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
A review of gliptins for 2014 2015 4 149 69%
Teneligliptin: expectations for its pleiotropic action 2015 3 33 61%
Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review 2011 113 98 89%
DPP-4 inhibitors in the management of type 2 diabetes: A critical review of head-to-head trials 2012 46 89 84%
Pharmacology of Dipeptidyl Peptidase-4 Inhibitors Similarities and Differences 2011 73 134 84%
Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and non-Asians: a systematic review and meta-analysis 2013 40 78 73%
Vildagliptin: A Review of Its Use in Type 2 Diabetes Mellitus 2014 8 122 84%
Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes 2015 1 118 72%
Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation 2015 1 59 71%
DPP-4 Inhibitors and Lipids: Systematic Review and Meta-Analysis 2012 54 31 58%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 THER EUT AREA METAB 31 92% 0.7% 12
2 STUDY GRP DIABET COMM 6 100% 0.2% 4
3 TRANSLAT SCI TRANSLAT MED 4 75% 0.2% 3
4 DIABET METAB TRANSLAT MED UNIT 3 39% 0.4% 7
5 DIABET NUTR METAB DISORDERS 3 14% 1.2% 20
6 DIABET COMM 2 67% 0.1% 2
7 EXPLORATORY PHARMACEUT 2 67% 0.1% 2
8 G DESCOVICH ATHEROSCLEROSIS STUDY 2 16% 0.6% 11
9 MEMPHIS VET AFFAIRS MED 2 43% 0.2% 3
10 NAMYANG 2 43% 0.2% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000242201 GLUCAGON LIKE PEPTIDE 1//EXENATIDE//LIRAGLUTIDE
2 0.0000215753 CD26//DIPEPTIDYL PEPTIDASE IV//SEPRASE
3 0.0000105271 INSULIN GLARGINE//INSULIN DETEMIR//BIPHASIC INSULIN ASPART 30
4 0.0000066439 PIOGLITAZONE//ROSIGLITAZONE//THIAZOLIDINEDIONES
5 0.0000065148 NATEGLINIDE//KAD 1229//REPAGLINIDE
6 0.0000064931 SGLT2 INHIBITOR//DAPAGLIFLOZIN//CANAGLIFLOZIN
7 0.0000060900 INTERMITTENT GLUCOSE//POSTPRANDIAL HYPERGLYCEMIA//GLYCEMIC VARIABILITY
8 0.0000054334 METFORMIN//LACTIC ACIDOSIS//METFORMIN ASSOCIATED LACTIC ACIDOSIS
9 0.0000052854 GLYCATED ALBUMIN//CHRONIC KIDNEY DISEASE DETECTION//CHRONIC KIDNEY DISEASE STAGES
10 0.0000048667 IDOP//DIABET OLDER PEOPLE IDOP//ADMINISTRATIVE HEALTH CARE UTILIZATION DATA